0001769132-19-000002.txt : 20190425 0001769132-19-000002.hdr.sgml : 20190425 20190425141007 ACCESSION NUMBER: 0001769132-19-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190425 DATE AS OF CHANGE: 20190425 EFFECTIVENESS DATE: 20190425 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Guide Therapeutics, Inc. CENTRAL INDEX KEY: 0001769132 IRS NUMBER: 832325333 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-333816 FILM NUMBER: 19766847 BUSINESS ADDRESS: STREET 1: 308 NORTHYARDS BLVD. NW STREET 2: STE B CITY: ATLANTA STATE: GA ZIP: 30013 BUSINESS PHONE: 404-937-3801 MAIL ADDRESS: STREET 1: 308 NORTHYARDS BLVD. NW STREET 2: STE B CITY: ATLANTA STATE: GA ZIP: 30013 D/A 1 primary_doc.xml X0708 D/A LIVE 0001769132 Guide Therapeutics, Inc. 308 NORTHYARDS BLVD. Suite B, NW ATLANTA GA GEORGIA 30013 404-937-3801 DELAWARE None None Corporation true 2018 Thomas Reese Saylor 380 Northyards Blvd. Suite B, NW Atlanta GA GEORGIA 30313 Executive Officer Director James Dahlman 380 Northyards Blvd. Suite B, NW Atlanta GA GEORGIA 30313 Director Andrew Perlman 380 Northyards Blvd. Suite B, NW Atlanta GA GEORGIA 30313 Director Boris Nikolic 380 Northyards Blvd. Suite B, NW Atlanta GA GEORGIA 30313 Director Other Technology Decline to Disclose 06b true 0001769132-19-000001 2019-02-15 false true false 0 6000000 6000000 0 false 2 0 0 0 false Guide Therapeutics, Inc. /s/ Thomas Reese Saylor Thomas Reese Saylor Chief Executive Officer 2019-04-25